Friday, 18 Jan 2019

RA/Inflammatory arthritis

Datesort ascending Type Title Save
17 Jan 2019 ACR Video QD Video - Enthesopathy-Related Arthritis
14 Jan 2019 ACR Video QD Video - Rheumatoid with but 1 Joint
10 Jan 2019 ACR Video QD6 - RA and Thrombocytopenia
08 Jan 2019 News Combo RA Treatment May Boost Risk for Serious Adverse Events
08 Jan 2019 ACR Video QD Video - Seronegative Arthritis
28 Dec 2018 Blog Best of 2018: 5 Mistakes When Diagnosing Adult-Onset Still’s Disease
20 Dec 2018 News Reassuring VTE Data for Tofacitinib
14 Dec 2018 Social RT @KDAO2011: While flu activity is starting to rise in US, CDC issued Updated Influenza Antiviral Medications Summary for Clinicians | CDC…
13 Dec 2018 Social No differences seen in the rates of major adverse CV events (MACE) between RA, axial SpA or PsA pts, suggesting inflammation, rather than a disease, drives CV risk. Data from a Swiss mixed retrospective/prospective cohort study https://t.co/Kn8a8tWId9
11 Dec 2018 News CV Risks Similar in Systemic Sclerosis and Rheumatoid Arthritis
11 Dec 2018 Social Systematic review of 41 papers shows that polymyalgia rheumatica is associated with comorbidities - CVA, CAD, peripheral arterial disease, diverticular disease, hypothyroidism, but there is disagreement as to an association betw PMR and cancer. https://t.co/74rwKuixR8
09 Dec 2018 Social RheumNow Podcast is Up - Can RA be Prevented? watch here https://t.co/enxuQcF0qf or listen on iTunes, Stitcher or Soundcloud https://t.co/nmK3h2ri7I https://t.co/qS33jbtaUt
06 Dec 2018 Social J. Hopkins study of 27 pts with inflammatory arthritis due to immune checkpoint inhibitors (mostly European ancestry) shows higher rate (61.5%) of at least 1 Shared Epitope allele (similar to RA pts) but were more likely to be seronegative for RF or CCP https://t.co/uR7ESZ2s07
05 Dec 2018 News PRAIRI Study - Can RA Be Prevented?
05 Dec 2018 Social CARRA reports it has completed enrollment of 403 newly diagnosed polyarticular JIA patients in STOP-JIA (Start Time Optimization of Biologic Therapy in Polyarticular JIA). Results anticipated in late 2019. https://t.co/V2qvZCRXvs
05 Dec 2018 Social Interdisciplinary guidelines for treating Uveitis in JIA - 1) Topical steroids; 2) if not improved, MTX; 3) Then TNF inhibitor; 4) systemic steroids; or 5) other biologics (TCZ, ABA, RTX). https://t.co/6D1aq3xQqA
04 Dec 2018 Social Cohort study 56866 RA/PsA/AS patients compared 287 w/ multiple myeloma & 2760 matched controls - no difference in MM risk related to biologic, DMARD or NSAIDs. But compared to DMARD only pts, Biologic + DMARD users had a 48% lower risk of MM (OR 0.52) https://t.co/DsmvNXC9c9
02 Dec 2018 Social FDA has approved Genentechs ACTpen - a tocilizumab autoinjector 162 mg sc for use in RA, GCA, poly and systemic JIA - should be available in January 2019. https://t.co/YzFHyYxQlS
02 Dec 2018 Social Study of 2053 RA patients from VA medical centers found 27% with chronic lung disease that confered a 51% increased mortality risk; sadly this was not altered by MTX or biologic therapy. https://t.co/nYFnScSXQ4
29 Nov 2018 News Rheumatoid Lung Disease Imposes Significant Morbidity and Mortality